Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00148642 · ClinicalTrials.gov registry record · Phase 3
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
A Phase 3 study, sponsored by C. R. Bard.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,003
- Enrollment target
NCT00148642: Completed Phase 3 study, sponsored by C. R. Bard.
NCT00148642 is a Phase 3 study that has completed, run by C. R. Bard. The registered enrollment target is 2,003 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (159% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00148642, a Phase 3 study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,003 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the use of a silver-coated endotracheal tube (ETT) can reduce the incidence and/or delay the time of onset of VAP when compared to a non silver-coated ETT in patients who have been mechanically ventilated for \>= 24 hours.
Interventions
- DEVICE silver salts coated endotracheal tube
- DEVICE uncoated endotracheal tube
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,003 participants |
| Start Date | 2002-11 |
| Est. Completion | 2006-03 |
| Phase | Phase 3 |
What the finished NCT00148642 record still lists
NCT00148642 is an interventional study that assigns participants to a tested intervention. Its 2,003 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (159% higher).
The record links to 0 conditions, and to 2 interventions - of which silver salts coated endotracheal tube is the first listed.
NCT00148642 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00148642 about?
NCT00148642 is a clinical study titled "Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)". The purpose of this study is to determine if the use of a silver-coated endotracheal tube (ETT) can reduce the incidence and/or delay the time of onset of VAP when compared to a non silver-coated ETT in patients who have been mechanically ventilated for \>= 24 hours.
What is the current status of trial NCT00148642?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,003 participants. The study started on 2002-11. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00148642?
The interventions under investigation include: silver salts coated endotracheal tube (DEVICE), uncoated endotracheal tube (DEVICE).
Who is sponsoring clinical trial NCT00148642?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00148642's enrollment target sits among peer trials
2,003 100th of 2000 higher than 1,901 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia